Development of a liquid-liquid extraction procedure for five 1,4-dihydropyridines calcium channel antagonists from human plasma using experimental design

被引:25
作者
Baranda, AB [1 ]
Etexbarria, N [1 ]
Jiménez, RM [1 ]
Alonso, RM [1 ]
机构
[1] Univ Basque Country, EHU, Dept Analyt Chem, Fac Sci & Technol, Bilbao 48080, Spain
关键词
1,4-dihydropyiridines; calcium channel antagonists; LLE; plasma and method optimization;
D O I
10.1016/j.talanta.2005.04.028
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A liquid-liquid extraction method using diethyl ether as organic solvent was optimized simultaneously for five 1,4-dihydropyfidines (amlodipine, nitrendipine, felodipine, lacidipine and lercanidipine) belonging to the group of calcium channel blockers. Some experimental tools such as a full factorial design, a central composite design and the Multisimplex program were used to optimise the concentration of NaOH, volume of organic solvent and shaking time as main factors that influence the liquid-liquid extraction procedure. Following the extraction, the quantitation of the 1,4-dihydropyridines concentrations were performed by high-performance liquid chromatography with diode-array detector. Therefore, the studied compounds were separated quantitatively on a Supelcosil ABZ+Plus, 25 cm x 4.6 mm i.d., 5 mu m column which was set at 30 degrees C, using as mobile phase, a mixture of acetonitrile-water (70:30, v/v) containing 10 mM acetate buffer (pH 5) and setting the detector at a wavelength value of 360 nm. It was concluded that the main factors that influence in the extraction process were the volume of organic solvent and the shaking time. The Multisimplex program suggested as optimal conditions an average of 6 ml of organic solvent and 23 min of shaking time. For these values, the optimised liquid-liquid extraction method showed good values of recoveries (80% for amlodipine and higher than 90% for the rest of the compounds) and low values of R.S.D. (<10%) in the reproducibility of the extraction what makes it reliable for the quantification of all the studied compounds in human plasma. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:933 / 941
页数:9
相关论文
共 46 条
[1]   Liquid chromatographic assay of nifedipine in human plasma and its application to pharmacokinetic studies [J].
Abou-Auda, HS ;
Najjar, TA ;
Al-Khamis, KI ;
Al-Hadiya, BM ;
Ghilzai, NM ;
Al-Fawzan, NF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (02) :241-249
[2]  
[Anonymous], 1986, PRACTICAL EXPT DESIG
[3]  
BARANDA AB, UNPUB J CHROMATOGR S
[4]  
Barchielli M., 1997, J CARDIOVASC PHARM, V29, P1, DOI [10.1097/00005344-199729002-00002, DOI 10.1097/00005344-199729002-00002]
[5]   QUANTIFICATION OF NITRENDIPINE IN PLASMA BY A CAPILLARY COLUMN GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC METHOD [J].
BECK, O ;
RYMAN, T .
JOURNAL OF CHROMATOGRAPHY, 1985, 337 (02) :402-407
[6]   ANALYSIS OF AMLODIPINE IN HUMAN-PLASMA BY GAS-CHROMATOGRAPHY [J].
BERESFORD, AP ;
MACRAE, PV ;
STOPHER, DA ;
WOOD, BA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 420 (01) :178-183
[7]   METABOLISM AND KINETICS OF AMLODIPINE IN MAN [J].
BERESFORD, AP ;
MCGIBNEY, D ;
HUMPHREY, MJ ;
MACRAE, PV ;
STOPHER, DA .
XENOBIOTICA, 1988, 18 (02) :245-254
[8]  
BERGSTROM O, 1998, MULTISIMPLEX 98
[9]  
Box G.E., 1978, STAT EXPT
[10]  
*CAMO AS, 1998, UNSCR US MAN